Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials.
Gerd-Rüdiger R BurmesterJayne StiglerAndrea Rubbert-RothYoshiya TanakaValderilio F AzevedoDerek CoombsIvan LagunesRalph LippePeter WungLianne S GenslerPublished in: Rheumatology and therapy (2024)
SELECT-AXIS 1: NCT03178487; SELECT-AXIS 2: NCT04169373; SELECT-PsA 1: NCT03104400; SELECT-PsA 2: NCT03104374.